Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?
Neth Heart J
.
2011 May;19(5):212-3.
doi: 10.1007/s12471-011-0119-z.
Authors
M D Smit
1
,
I C Van Gelder
Affiliation
1
Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, the Netherlands.
PMID:
21487742
PMCID:
PMC3087023
DOI:
10.1007/s12471-011-0119-z
No abstract available